Default Category
-
Shenzhen Capital Group
Gompers, Paul A.; Chen, Shaohui; Lin, Jessie; Ling, ShelleyCase HBS-211029-EFinanceHaitao Jin, Chairman of Shenzhen Capital Group Co., Ltd. ("SCGC") and Wanshou Li, President of the SCGC must decide how to continue to grow their venture capital/private equity firm in China. SCGC is a premier VC/PE fund in China and a pioneer of the Government Sponsored Fund (GBF) structure. The firm had grown to RMB 20 billion in just ten years and had funds in 29 different cities across China. As competition for investments becomes more intens...Starting at €8.20
-
Motilal Oswal Financial Services Ltd.: An IPO in India, Teaching Note
Lerner, Josh; Hardymon, G. Felda; Leamon, AnnTeaching Note HBS-809018-EFinanceTeaching Note for [807095].Starting at €0.00
-
Gobi Partners: Raising Fund II
Hardymon, G. Felda; Leamon, AnnCase HBS-807093-EFinanceThe three founding partners of Gobi Partners, a venture capital fund investing in early start IT and digital media companies in China, are planning to raise a second fund. The first $51.75 million fund is close to being entirely invested and the portfolio companies are doing well, with two having raised subsequent financings at significantly increased valuations. The firm itself has increased its headcount and opened a second office, but it has n...Starting at €8.20
-
Gobi Partners: Raising Fund II, Teaching Note
Hardymon, G. Felda; Lerner, Josh; Leamon, AnnTeaching Note HBS-808052-EFinanceTeaching Note for [808052].Starting at €0.00
-
The Blackstone Group's IPO
Hardymon, G. Felda; Lerner, Josh; Leamon, AnnCase HBS-808100-EFinanceSteven Schwarzman, Chairman of the Blackstone Group, has just learned that an investment group associated with the government of China wants to buy the majority of Blackstone's leveraged IPO. As he considers how to respond to this offer, Schwarzman reviews the firm's proposed structure as a public entity and assesses how he might retain the delicate balance among stakeholders while still maintaining liquidity in the market.Starting at €8.20
-
Digital Media Group: The Shanghai Bid
Hardymon, G. Felda; Leamon, AnnCase HBS-810099-EEntrepreneurshipIn December 2008, Thomas G. Tsao, acting CEO of Digital Media Group (DMG), a venture-backed provider of technology and media used primarily in subways, must decide how to structure the company's bid for the advertising concession in Shanghai's 13 existing and planned subway lines. This is complicated by the fact that he is also a general partner in Gobi Partners, one of DMG's largest investors. The company is bidding against its largest competito...Starting at €8.20
-
The Abraaj Group and the Acibadem Healthcare Investment (A)
Gompers, Paul A.; Uluduz, Bora; Abacioglu, FirdevsCase HBS-214021-EFinanceThis case concerns the proposed buyout of Acibadem, a leading hospital chain in Turkey. Abraaj, a MENA region private equity firm, proposes to make its first investment in Turkey. The case highlights the role of Turkish health care reform in driving the value. The case provides an opportunity to estimate the potential return on investment as well as evaluate the structuring of the transaction.Starting at €8.20
-
Advantage Partners: Dia Kanri (A)
Gompers, Paul A.; Sato, Nobuo; Kanno, AkikoCase HBS-214016-EFinanceThis case explores the opportunity to purchase the condominium management business of a distressed real estate developer by Advantage Partners, a leading Japanese private equity firm. The case explores investment structuring, bidding strategy, and the ability of private equity firms to add value. The role of private equity in Japan is also explored and allows students to compare the Japanese merger and acquisition market to the U.S. and Europe.Starting at €8.20
-
Advantage Partners: Dia Kanri (B)
Gompers, Paul A.; Sato, Nobuo; Kanno, AkikoCase HBS-214017-EFinanceThis case presents the final decision and outcomes for the (A) case.Starting at €5.74
-
The Abraaj Group and the Acibadem Healthcare Investment (B)
Gompers, Paul A.; Uluduz, Bora; Abacioglu, FirdevsCase HBS-214022-EFinanceThis case provides an update on the ultimate outcome of the transaction presented in The Abraaj Group and the Acibadem Healthcare Investment (A).Starting at €5.74